Objectives
1. To evaluate study on effects of rituximab or cyclosporine in the treatment of membranous nephropathy.
2. To determine clinical significance of study results.
Session date:
10/03/2019 - 1:00pm to 2:00pm CDT
Location:
UCMC, AMB W-507
5700 S Maryland Ave
Chicago, IL
60637
United States
See map: Google Maps
Add to calendar:
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Speaker Name:
Dr. Nevin Murthy